维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="LEICHTMAN AB"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Morbidity and mortal- ity after living kidney donation, 1999-2001 : Survey of United States transplant centers显示文摘	Matas AJ Bartlett ST Leichtman Ab	2003	Am J Transplant2003，3，7：	1
2	Erythromycin breath test predicts oral clearance of cyclosporine in kidney transplant recipients显示文摘	Turgeon DK Normolle DP Leichtman AB	1992	Clin Pharmacol Ther1992，52，5：	1
3	查看详情显示文摘	Meier Kriesche HU Ojo AO Leichtman AB		0，，：	1
4	Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant out- comes 显示文摘	Ojo AO Leichtman AB Punch JD	2000	Am J Kidney Dis2000，36，1：	1
5	Role of intestinal P-glycoprotein(mdrl) in interpatient variation in the oral bioavailability of cyclosporine 显示文摘	Lown KS Mayo RR Leichtman AB	1997	Clin Pharmacol Ther1997，62，3：	1
6	Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine显示文摘	LOWN K S MAYO R R LEICHTMAN AB	1997	Clin Pharmacol Ther1997，62，3：	1
7	P450 3A activity and cyclosporine dosing in kidney and heart transplant recipients显示文摘	Turgeon DK Leichtman AB Lown KS		0，，03：	1
8	Impact of pre existing donor hyper-Tension and diabetes mellitus on cadaveric re nal transplant outcomes显示文摘	Cjo AO Leichtman AB Punch JD	2000	Am J Kidney Dis2000，36，1：	1
9	Role of intestinal P-glycoprotein (mdrl) in interpatient variation in the oral bioavailability of cyclosporine显示文摘	Lown KS Mayo RR Leichtman AB Hsiao HL Turgeon DK Schmiedlin-Ren P	1997	Clin Pharmacol Ther1997，62，：	1
10	Role of intesti-nal P-glycoprotein (mdrl) in interpatient variation in theoral bioavailability of cyclosporine显示文摘	Lown KS Mayo RR Leichtman AB	1997	Clin Pharmacol1997，62，3：	1
11	Erythromycin breath test predicts oral clearance of cyclosporine in kidney transplant recipients显示文摘	Normolle DP Leichtman AB Annesley TM Smith DE Watkins PB	1992	Clin Pharmcol Ther1992，52，5：	1
12	Morbidity and mortality after living kidney donation,1999-2001:survey of United States Transplant Centers 显示文摘	MATAS AJ BARLETT ST LEICHTMAN AB	2003	Am J Transplant2003，3，：	1
13	Erythromycin breath test predicts oral clearance of cyclosporine in kidney transplant recipients显示文摘	Turgeon DK Normolle DP Leichtman AB	1992	Clin Pharmacol Ther1992，52，5：	1
14	Morbidity and mortality after living kidney donation,1999-2001:survery of United States transplant centers显示文摘	Matas AJ Bartlett ST Leichtman AB	2003	Am J Transplant2003，3，7：	1
15	Role of intestinal P-glycoprotein(mdr1) in interpatient variation in the oral bioavailability of cyclpsporine显示文摘	Lown KS Mayo RR Leichtman AB	1997	Clin Pharmacol Ther1997，62，3：	1
16	Role of intestinal P - glycoprotein ( mdr1 ) in interpatient variation in the oral bioavailability of cyclosporine 显示文摘	Lown KS Mayo RR Leichtman AB	1997	Clin Pharmacol Ther1997，62，：	1
17	Role of intestinal Pglycoprotein (mdrl) in interpatient variation in the oral bioavailability of cyclosporine显示文摘	Mayo RR Leichtman AB	1997	Clin Pharmacol Ther1997，62，：	1
18	Determinants of discard of expanded criteria donor kidneys:impact of biopsy and machine perfusion显示文摘	Sung RS Christensen LL Leichtman AB	2008	Am J Transplant2008，8，4：	1
19	Role of intestinal P-glyco- protein ( mdrl ) in interpatient variation in the oral bioavailability of cy- elosporine 显示文摘	Lown KS Mayo RR Leichtman AB	1991	Clin Pharmacol Ther1991，62，3：	1
20	Morbidity and mortality after living kidney donation, 1999-2001: survery of United States transplant centers 显示文摘	Matas AJ Bartlett ST Leichtman AB	2003	Am J Transplant2003，3，7：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示